Nasogastric Tube Insertion Using Midazolam in the Emergency Department
Completed · Phase 4 · Has a placebo group
Conditions studied: Intubation; Difficult
In brief
Nasogastric tube placement involves insertion of a flexible tube through the nose into the stomach. Placement of the tube can irritate the nose and palate and trigger gagging, causing discomfort, even if topical or local anesthetics are used. This study aims to determine if administration of an ultra-short acting sedative agent (midazolam) into a vein before the procedure, in addition to topical local anesthetic, will decrease the level of discomfort.
Key facts
- Study ID
- NCT01375634
- Run by
- University of Vermont
- People needed
- 49
- Starts
- 2011-05-01
- Expected to finish
- 2013-04-01
- Last updated by the study team
- 2013-07-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- at least 18 years old
- Receiving a nasogastric tube by a registered nurse at Fletcher Allen Health Care
You may not qualify if…
- less than 18 years old
- weight < 40 kg
- Need immediate nasogastric tube placement
- Endotracheal intubation
- Hemodynamically unstable
- Non-English speaking
- Without capacity to provide informed consent
Where it is running
- Fletcher Allen Health Care Emergency Department — Burlington, Vermont, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.